Related Experiment Video
Updated: Jul 15, 2025
08:53
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
Published on: August 31, 2016
15.3K
Updates on the mobilization pipeline for hematopoietic stem cell collection
Minh-Ha Tran1, Muharrem Yunce2
1University of California, Irvine School of Medicine, Irvine, California, USA.
Journal of Clinical Apheresis
|September 25, 2023
Summary
Hematopoietic stem cell transplantation relies on stem cell mobilization for apheresis. This review examines current and emerging mobilizing agents to improve patient outcomes in stem cell collection.
Area of Science:
- Hematology
- Transplantation Medicine
Background:
- Hematopoietic stem cell transplantation (HSCT) is a critical life-saving procedure.
- Successful HSCT necessitates the effective mobilization of stem cells for apheresis.
Purpose of the Study:
- To review existing and investigational agents used for stem cell mobilization.
- To inform apheresis practitioners about the latest advancements in mobilization strategies.
Main Methods:
- Literature review of scientific publications and clinical trials.
- Analysis of data on efficacy and safety of various mobilizing agents.
Main Results:
- Overview of commonly used mobilizing agents (e.g., G-CSF).
- Discussion of novel agents and combination therapies under investigation.
- Highlighting factors influencing mobilization efficiency.
Conclusions:
- Familiarity with diverse mobilization agents is crucial for apheresis practitioners.
- Optimizing stem cell mobilization enhances patient outcomes in HSCT.
- Continuous evaluation of new agents is essential for advancing transplantation medicine.
Related Concept Videos
01:21Hematopoiesis
5.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.4K
01:22Bone Marrow Sampling and Transplants
352
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
352
01:19Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K